Perioperative Anticoagulation for Hip and Knee Replacements
For patients undergoing primary total hip or knee arthroplasty, use LMWH (enoxaparin 40 mg once daily starting 12-24 hours after surgery OR 30 mg twice daily starting 12-24 hours after surgery), fondaparinux, or a direct oral anticoagulant (rivaroxaban, apixaban, or dabigatran) for VTE prophylaxis, continuing for a minimum of 10-14 days for knee replacement and 28-35 days for hip replacement. 1, 2, 3
Recommended Pharmacological Agents
The evidence supports several first-line options with comparable efficacy:
LMWH (Low Molecular Weight Heparin)
- Enoxaparin 40 mg once daily starting 12-24 hours postoperatively, OR
- Enoxaparin 30 mg twice daily starting 12-24 hours postoperatively
- Both regimens are accepted as standard clinical practice worldwide 4
- The twice-daily regimen (60 mg total daily dose) may be superior for knee arthroplasty 4
Direct Oral Anticoagulants (DOACs)
- Rivaroxaban 10 mg once daily (standard prophylaxis dose) 2
- Apixaban 2.5 mg twice daily 5
- Dabigatran 220 mg once daily (starting with 110 mg half-dose 1-4 hours post-surgery, then 220 mg daily) 4
- DOACs are noninferior to enoxaparin for VTE prevention 2, 6
Alternative Agents
- Fondaparinux 2.5 mg once daily starting 6-8 hours postoperatively 2, 3
- Warfarin (target INR 2.5, range 2.0-3.0) 1, 3
- Aspirin (81-325 mg daily) - increasingly used but remains controversial; best reserved for standard-risk patients 6, 7, 8, 9
Duration of Prophylaxis
Total Knee Arthroplasty
- Minimum 10-14 days of prophylaxis 1, 2, 3
- Extended prophylaxis beyond 14 days is not routinely recommended for TKA 1
Total Hip Arthroplasty
- Minimum 10-14 days, but strongly recommend extending to 28-35 days 1, 2, 3
- Extended prophylaxis significantly reduces late VTE events that occur after hospital discharge 1
Timing of Initiation
Critical timing considerations:
- LMWH: Start 12-24 hours after surgery (NOT before surgery in most protocols) 1
- DOACs: Dabigatran can start 1-4 hours post-surgery with half-dose; rivaroxaban and apixaban typically 6-10 hours post-surgery 4
- Fondaparinux: Start 6-8 hours postoperatively 2
- Earlier initiation (evening before surgery) increases bleeding risk without clear VTE benefit 4
Mechanical Prophylaxis
Mechanical methods should be used as adjuncts, not sole therapy:
- Intermittent pneumatic compression (IPC) or graduated compression stockings can supplement pharmacological prophylaxis 10
- Use mechanical prophylaxis alone ONLY in patients at very high bleeding risk 10, 3
- Mechanical methods have lower efficacy than pharmacological agents and suffer from poor compliance after discharge 10
Special Considerations for Patients on Chronic Anticoagulation
For patients already on long-term oral anticoagulants (warfarin or DOACs):
Preoperative Management
- Stop warfarin 3-5 days before surgery 9
- Stop DOACs 2-3 days before surgery (depending on renal function) 9
- Avoid LMWH bridging - it significantly increases bleeding complications (37% HTR complication rate with bridging vs 13% without) 11
Postoperative Resumption
- DOACs: Resume 24-48 hours postoperatively once hemostasis achieved 11
- Warfarin: Resume evening of surgery or next day; overlap with LMWH until INR therapeutic is NOT recommended due to increased bleeding 11
- Patients on VKA had 35% HTR complication rate vs 15% for DOA patients 11
Agent Selection Algorithm
Choose based on these factors:
Standard-risk patients: LMWH, rivaroxaban, apixaban, or aspirin (if validated risk stratification confirms low risk) 6, 7, 9
High bleeding risk: Mechanical prophylaxis alone or delayed pharmacological prophylaxis 10, 3
Convenience/compliance concerns: DOACs preferred over LMWH (oral administration, no monitoring, easier outpatient use) 7
Cost considerations: Aspirin is least expensive, but efficacy data from rigorous RCTs still needed 8, 9
Renal dysfunction: Avoid dabigatran and fondaparinux; adjust LMWH dosing 7
Common Pitfalls to Avoid
⚠️ Do NOT use aspirin as sole prophylaxis without risk stratification - guidelines explicitly recommend against aspirin alone for high-risk patients 3
⚠️ Do NOT start LMWH the evening before surgery - this European protocol increases bleeding without clear benefit 4
⚠️ Do NOT use LMWH bridging for patients on chronic anticoagulation - it doubles bleeding complications 11
⚠️ Do NOT stop prophylaxis at hospital discharge for hip arthroplasty - extend to 28-35 days as most VTE events occur post-discharge 1, 3
⚠️ Do NOT use mechanical prophylaxis alone in standard-risk patients - it is inferior to pharmacological agents 10, 3
Bleeding vs. Thrombosis Trade-offs
The evidence shows balanced risks:
- LMWH and DOACs have similar major bleeding rates (1.4-1.5%) 2
- Symptomatic VTE rates with prophylaxis: 0.5-1% 2
- The goal is preventing symptomatic VTE (DVT/PE) and death, not asymptomatic venographic DVT 10
Recent high-quality evidence suggests aspirin <325 mg daily may offer the best balance of efficacy and safety (SUCRA-VTE 89.3%, SUCRA-bleeding 75.3%) in appropriately selected patients, though this remains debated 6, 8, 9.